2529: Understanding the Genetics of Adverse Drug Reactions in Sighthounds: Phase II
Grant Status: Open
Life-threatening unanticipated reactions to drugs with a narrow margin of safety, such as those used for anesthesia and to treat cancer, are a common yet serious concern for dog owners and veterinarians. Investigators at Washington State University have been conducting research to identify the cause of extremely slow recovery from anesthesia in a high proportion of Greyhounds, as well as in other sighthound breed dogs, including Italian Greyhounds, Scottish Deerhound, Borzois, Irish Wolfhounds, Salukis, Afghans, and Whippets (among others). In previous work funded by the AKC Canine Health Foundation (#02242), the investigators have discovered several mutations that were shown by cell-based testing to significantly decrease the function of genes responsible for breaking down (metabolizing) commonly used anesthetic drugs, as well as many other drugs used in dogs. The goal of this next phase of the research is to develop a novel drug sensitivity test using saliva, blood or urine samples to identify dogs within a breed (or specific breeds) that metabolize drugs very slowly, thus creating a "personalized" or individual dog approach to drug selection. This test will then be used to confirm that the identified gene mutations are the cause of slow drug metabolism in sighthound dog breeds - as well as identify other breeds and individual dogs that could suffer from similar adverse drug reactions.
None at this time.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.